To characterize the phenotype of obesity on a high-carbohydrate diet (HCD) as compared to a high-fat diet (HFD) or moderate-fat diet (MFD).
Introduction
Obesity is an increasing health problem in affluent countries, with the overeating of energy-and fat-rich foods implicated in the rise of obesity. [1] [2] [3] Dietary fat is a significant contributor to hyperphagia, weight gain, and fat deposition, with body fat increasing in direct proportion to the fat content of the diet. 4 Together with elevated body fat, longterm high-fat diet (HFD) consumption causes a rise in circulating levels of leptin, insulin, triglycerides (TG), and glucose. 5, 6 Its metabolic effects include an increase in lipoprotein lipase (LPL) activity in adipose tissue, which enhances the uptake of excess lipids, 6 and a reduction in energy expenditure, sympathetic nervous system activity, and carbohydrate oxidation in muscle. [6] [7] [8] In addition to fat consumption, there is evidence that the overeating of carbohydrate may also contribute to obesity. 9, 10 Whereas rats maintained on a high-carbohydrate diet (HCD) invariably weigh less than those on a fat-rich diet or even a balanced, moderate-fat diet (MFD), 4, 11, 12 the addition of a sucrose solution to the diet causes a marked increase in body fat accrual, even without a rise in total caloric intake. [13] [14] [15] Moreover, a carbohydrate-rich diet or meal compared to a balanced diet stimulates the secretion of the anabolic hormone, insulin, which promotes body fat synthesis. 4, 11, 16 It raises circulating levels of corticosterone (CORT), 4, 11 which has lipogenic effects of its own or together with insulin, 17, 18 and it increases circulating glucose, which is used for the process of de novo lipogenesis. 16, 19 It also increases the expression of neuropeptide Y (NPY) and agoutirelated protein (AGRP), which are known to promote obesity. [20] [21] [22] Thus, whereas the direct effects of dietary carbohydrate and fat clearly differ, both macronutrients contribute to the process of body fat accrual through either fat synthesis or fat storage, respectively. 2, 3, 16 There are few studies, however, that have actually compared obese to lean rats maintained on an HCD. The limited evidence indicates that hyperinsulinemia and hyperleptinemia are evident in obese animals whether on an HFD or HCD, [23] [24] [25] while dietary fat is a critical stimulus for producing hyperglycemia as well as hyperphagia. 26 In contrast, sucrose-or starch-rich diets reveal in obese rats increased carbohydrate metabolism in muscle, which is not evident in obese animals on an HFD. 27, 28 Thus, diet composition appears to be an important factor in revealing physiological processes that are abnormally regulated in obesity. There are no studies, however, that in the same report have directly compared the types of obesity produced by different diets. Also lacking are such investigations of hypothalamic peptides, which are known to have a role in eating and body weight regulation. 29 One such peptide, galanin (GAL), may be particularly informative, as it is found to be stimulated by consumption of an HFD and to be closely related to circulating levels of TG that rise with obesity. 6, 11, 30 Differential expression patterns of this peptide in obese rats as a function of diet may help to elucidate not only the specific factors controlling this peptide in physiological states, but also the mechanisms that underlie different forms of obesity. Thus, the purpose of the present study was to characterize the phenotype of rats that become obese on diets with differential fat and carbohydrate content. Specifically, the objectives were to: (1) test and compare three diets in one study, using the same procedures and diet constituents for each experiment while simply varying the fat and carbohydrate composition of these diets; (2) examine a variety of behavioral, endocrine, and metabolic systems, to provide an extensive analysis of the disturbances and different types of obesities that may develop as a function of diet; and (3) relate these various physiological measures to hypothalamic GAL, in an effort to understand how this peptide is regulated and, in turn, how it may act to promote obesity under the different dietary conditions. Three sets of rats were maintained for several weeks on one of three diets, an HFD with 50% fat, a balanced MFD with 25% fat and 50% carbohydrate, or an HCD with 65% carbohydrate, of which 70% was sucrose. These rats in each set were, then, separated into lean and obese subgroups, based on the weight of their fat pads at the end of the experiment. With a wide variety of measures, these experiments revealed clear differences between the phenotypes of obese rats on the HFD vs HCD and provide evidence supporting the idea that different central and peripheral mechanisms underlie these different types of obesity.
Methods and procedures
Subjects Adult, male Sprague-Dawley rats (275-300 g; Charles River Breeding Labs, Kingston, NY, USA) were individually housed (221C, with lights off at 1530 h for 12 h), in a fully accredited American Association for the Accreditation of Laboratory Animal Care facility, according to institutionally approved protocols as specified in the NIH Guide to the Use and Care of Animals and also with the approval of the Rockefeller University Animal Care Committee. All animals were given 1 week to acclimalize to lab conditions, during which time they were maintained ad libitum on laboratory chow and water. All protocols fully conformed to the Guiding Principles for Research Involving Animals and Human Beings. 31 
Diets
All rats were maintained ad libitum on one of three diets, an HFD, a balanced MFD, or an HCD. As outlined in Table 1 , the constituents of these diets were: fat with lard (Armour) and vegetable oil (Wesson); carbohydrate with 30% dextrin, 30% 
Experimental procedures
Following a 1-week period of adaptation to the lab conditions and chow diet, the rats were given three, 2-h exposures at dark onset to one of the test diets, namely, the HFD (Experiments 1 and 4), MFD (Experiment 2), or HCD (Experiments 3 and 4). They were, then, given ad libitum access to these diets for 3 weeks on the HFD and MFD and for a longer 5-week period on the HCD to allow more time for the rats to exhibit sufficient weight gain and body fat accrual. Food intake measurements were taken twice weekly and body weight once a week. At the end of the experiment, the rats were killed by decapitation 1-2 h before the onset of the dark period and spontaneous feeding. Trunk blood was collected for analysis of the hormones, leptin, insulin, and CORT, and the metabolites, TG, nonesterified fatty acids (NEFA), and glucose. Unilateral body fat pads from three regions (retroperitoneal, gonadal, and inguinal tissue), as well as the mesenteric fat pad, were collected at the time of decapitation and weighed, with total fat pad weights recorded as a sum of the four individual fat pads. Strong positive correlations (r ¼ þ 0.82 to þ 0.96) were obtained between the weights of the individual fat pads and total dissected body fat, and the percent of total weight accounted for by the retroperitoneal (21%), gonadal (19%), inguinal (35%), and mesenteric (25%) fat pads was very consistent across diets. Thus, the data obtained for the individual fat pads were not further analyzed. Samples of retroperitoneal fat were collected and frozen in liquid nitrogen for subsequent analysis of LPL activity. The gastrocnemius muscle was also rapidly dissected and frozen in liquid nitrogen for subsequent analysis of the metabolic enzyme activities, LPL, b-hydroxyacyl-CoA dehydrogenase (HADH), phosphofructokinase (PFK), and citrate synthase (CS). Brains were rapidly removed. In Experiments 1-3, they were fixed in 4% paraformaldehyde for mRNA and peptide analyses using in situ hybridization and immunocytochemistry, respectively. In Experiment 4, they were placed in a matrix with the ventral surface facing up, and two 1.0 mm coronal sections were made, with the middle optic chiasma as the anterior boundary. The sections were placed on a glass slide, and the PVN (Bregma À1.3 to À2.1 mm) was rapidly microdissected under a microscope, using the fornix and third ventricle as landmarks. The dissections were immediately frozen in liquid nitrogen and stored at À801C until processed.
Hormone and metabolite determinations Serum from trunk blood was assayed for insulin and leptin, using assay kits from Linco Research Inc. (MO, USA). Levels of CORT were determined by RIA using a kit from Diagnostic Products Corporation (CA, USA). Serum levels of glucose, TG, and NEFA were analyzed using a commercially available serum chemistry analyzer at Amgen Inc. (CA, USA).
Measurements of enzyme activity
Analyses of aLPL and mLPL activity were performed by Dr Susan Fried at the University of Maryland School of Medicine (Baltimore, MD, USA) using procedures described elsewhere. 32 One unit of LPL activity is defined as the release of 1 mmol free fatty acid in 1 h. Assays for HADH, PFK, and CS activity in gastrocnemius muscle were conducted by Drs James Hill and Ellis Gayles at the Center for Human Nutrition, University of Colorado (Denver, CO, USA). 33 Enzyme data are presented as absolute reaction rates, in mmol/g/min.
In situ hybridization After rapid decapitation, brains were removed immediately and fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) at 41C for 3 days and cryoprotected in 25% sucrosephosphate buffer at 41C for a further 48 h, then frozen at À801C until day of use. For the experiments, brains were cut into 30 mm thick sections using a cryostat. A consistent angle of cut was maintained by examining the shape of the third ventricle. Brains within a given experiment were always processed at the same time to maintain stringent tissue preparation and staining conditions. For in situ hybridization, a digoxigenin (DIG)-labeled antisense RNA probe was in vitro transcribed, as described. 11 Free-floating coronal sections were consecutively treated as follows: 10 min in 0.001% proteinase K, 5 min in 4% paraformaldehyde, 10 min each in 0.2 N HCl and acetylation solution, and 18 h in hybridization buffer (at 551C), between each step 2 Â 5 min wash in PB(0.1 M pH7.2). This was followed by 20 min in 5 Â SSC, 30 min in 50% formamide, both at 601C, 30 min in RNase A (1 mg/ml) at 371C. Then, there was 16 h incubation in AP-conjugated sheep anti-DIG Fab fragments (1:500, Boehringer Mannheim) at room temperature and 6 h in freshly prepared color developer (50 ml 4-nitroblue tetrazotium chloride solution, 37.5 ml 5-bromo-4-chloro-3-indolyl-phosphate solution in 10 ml Tris buffer, pH 9.5 (Boehringer Mannheim). Finally, the sections were fixed for 10 min in 4% paraformaldehyde, then mounted, air-dried, dehydrated, cleared and coverslipped. The sense probe control was performed in the same tissue, and no signal
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Immunocytochemistry
Adjacent free-floating coronal sections from brains prepared for in situ hybridization (see above) were used for immunocytochemistry. The free-floating sections were pretreated in an 80% methanol PBS solution containing 0.03% H 2 O 2 for 30 min, followed by a 30 min blocking in 5% normal goat serum PBS containing 0.5% Triton X-100, then incubated in rabbit anti-GAL polyclonal serum (1:15,000, supplied by Dr Steven M Gabriel, Mt Sinai School of Medicine, New York, NY, USA) overnight, followed by 1 h incubation in biotinylated goat anti-rabbit IgG (1:200, Vector laboratories, Inc., CA, USA) and 2 h incubation in standard Vectastain ABC (1:300, Vector laboratories, Inc., CA, USA). GAL immunoreactivity (GAL-ir) was revealed by 10 min incubation in 0.05% DAB/ 0.03% H 2 O 2 /0.05 M Tris-HCl buffer (Sigma). Between each step, the sections were rinsed 3 Â 5 min in PBS (0.01 M, pH 7.4). Finally, the sections were mounted, air-dried, dehydrated, cleared, and coverslipped. All procedures were conducted at room temperature, unless otherwise indicated.
Semiquantification of in situ hybridization and immunocytochemistry
Sections were viewed using a Leitz microscope with a 10 Â illumination objective, and images were captured with a Nikon DXM 1200 digital camera. Captured image was analyzed using Image-Pro Plus software (Version 4.5, Media Cybernetics Inc., Silver Spring, MD 20910, USA) on a grayvalue scale from 1 to 255. Two hypothalamic areas with a dense concentration of GAL neurons were examined. These areas, with coordinates according to the atlas of Paxinos and Watson, 34 were the anterior-medial region of the PVN, where GAL is expressed in parvocellular neurons (Bregma À1.3 to À1.4 mm), and the arcuate nucleus (ARC) (Bregma À2.8 mm). A total of 10 sections at the same level in each nucleus were examined in each animal. The nucleus was outlined, and the number of GAL neurons and fibers in this area was counted and expressed as number of GAL neurons/ mm 2 and GAL objects/mm 2 , respectively. Average density in each area for different groups was compared and statistically analyzed. Before measurement, a threshold was first established. Using 10 randomly selected sections from the experiment, this threshold was set by matching the number of objects counted by the software in a defined area of each section with the number of objects counted manually in that same area. The values obtained were 100 for mRNA and 65 for peptide-ir. When these numbers of objects were found to match in all 10 sections, this threshold value, which varied across areas, was kept constant and used for all sections viewed within a given experiment. The analyses were performed by an observer blind to the identity of the animals.
Real-time quantitative PCR As previously described, 35 total RNA from pooled microdissected whole PVN was extracted with TRIzol reagent. RNA was treated with RNase-free DNase I before RT. For quantitative PCR, cDNA, and minus RT were synthesized using an oligo-dT primer with or without SuperScript II Reverse Transcriptase. The SYBR Green PCR core reagents kit (Applied Biosystems, CA, USA) was used, with b-actin as endogenous control. PCR was performed in MicroAmp Optic 96-well reaction plates (Applied Biosystems) on an ABI PRISM 7700 Sequence Detection system (Applied Biosystems), with the condition of 2 min at 501C, 10 min at 951C, then 40 cycles of 15 s at 951C, and 1 min at 601C. Each study consisted of four independent runs of PCR in triplicate, and each run included a standard curve, nontemplate control, and negative RT control. The levels of GAL gene expression were quantified relative to the level of b-actin, using standard curve method. The primers, designed with ABI Primer Express V.1.5a software based on published sequences, were: 5 0 -GGCCAACCGTGAAAAGATGA-3 0 (forward) and 5 0 -CACAGCCTGGATGGCTACGT-3 0 (reverse) for b-actin and 5 0 -TTCCCACCACTGCTCAAGATG-3 0 (forward) and 5
0 -TGGCTGACAGGGTTGCAA-3 0 (reverse) for GAL. The concentrations of primers were 100-200 nM, and all reagents, unless indicated, were from Invitrogen.
Data analysis
All values are expressed as mean7s.e.m. Values for total caloric intake (kcal/day) are given for individual weeks in the text and as an average across all weeks in the tables. The scores for body weight and body fat pad weights given in the tables reflect the measures taken on the day the rats were killed. Statistical analyses of the different measures for the obese vs lean groups within each experiment were performed using an unpaired Student's t-test. Further analyses using two-factor ANOVA were performed to compare the obese phenotypes as a function of diet. Within-group measures of GAL were related to hormones, metabolites, and metabolic enzyme activity using a Pearson's product moment correlation. The criterion for the use of the term 'significant' in the text is that the probability value (P) for a given test is o0.05.
Results
The experiments of this study examined five sets of rats (n ¼ 25-27/set, 285-310 g), which were maintained for several weeks on an HFD (50% fat/25% carbohydrate), balanced MFD (25% fat/50% carbohydrate), or HCD (65% carbohydrate/10% fat). Based on their fat pad weights, they were rank ordered and separated into lean (lowest tertile) and obese (highest tertile) subgroups (n ¼ 8-9/group), and their measures were compared. In Experiments 1-3, GAL mRNA was measured using in situ hybridization and GAL Obesity on a high-carbohydrate vs high-fat diet JT Dourmashkin et al peptide using immunocytochemistry. In Experiment 4, GAL mRNA was measured using real-time quantitative PCR. Experiment 1: obesity on an HFD with 50% fat In this experiment, the rats were maintained for 3 weeks on an HFD with 50% fat and were divided into two subgroups (n ¼ 9/group) with fat pad weights of 15.271.5 g for the lean rats and 27.172.0 g for the obese rats.
Body weight, adiposity, and food intake measures. The rats considered obese, with 80% greater fat pad weights than the lean rats, were approximately 60 g heavier in body weight ( Table 2 ). They had greater % body fat (fat pad weight/body weight), exhibited more rapid weight gain, and showed a 15% increase in food intake across the 3-week period, an effect apparent during week 1 (94 vs 115 kcal, Po0.01) and week 2 (92 vs 111 kcal, Po0.05) but not week 3 (87 vs 95 kcal, NS).
Physiological measures. In the obese rats, levels of leptin and insulin were elevated by 35-45%, whereas levels of CORT were significantly reduced by 40% ( Table 2 ). The obese animals also had elevated glucose levels, together with higher lipids, both TG and NEFA. In addition, they exhibited a significant increase in HADH activity in muscle, with no change in PFK or CS activity ( Table 2 ). The measure of LPL activity, an indicator of TG transport, was markedly elevated in adipose tissue but unchanged in muscle.
GAL measures. Consistent with published evidence, 11 a 20-30% increase in GAL mRNA and peptide-ir was seen in the obese compared to lean rats ( Table 2 ). This effect was evident specifically in the PVN, the anterior parvocellular region, but not in the ARC (Figure 1 ). This site-specificity was supported by significant, positive correlations between TG levels and GAL in the PVN (mRNA: r ¼ þ 0.73, Po0.01; peptide-ir: Obesity on a high-carbohydrate vs high-fat diet JT Dourmashkin et al Experiment 2: obesity on an MFD with 25% fat With procedures identical to Experiment 1, the lean and obese rats (n ¼ 8/group) maintained for 3 weeks on an MFD (25% fat) had body fat pad weights of 12.070.6 g and 20.270.9 g, respectively, with the obese animals exhibiting characteristics generally similar to those of obese rats on an HFD (50% fat).
Body weight, adiposity, and food intake measures. With 65% higher fat pad weights, the obese rats on the MFD had greater body weight ( þ 65 g), % body fat pad weights, and weight gain (Table 3) . They exhibited hyperphagia in the 3-week measure (Table 3) , with increased caloric intake apparent during week 1 (86 vs 104 kcal, Po0.01) and week 2 (79 vs 93 kcal, Po0.05) but not week 3 (74 vs 85 kcal, NS). These changes in MFD obese rats were similar in magnitude to those exhibited by the obese HFD rats (Table 2) , despite their 25% smaller fat pad weight (20.2 g vs 27.1 g).
Physiological measures. As on the HFD, leptin, and insulin levels were significantly elevated in the obese rats on the MFD, while CORT levels were reduced (Table 3) . Also, the measures of metabolites revealed a significant increase in TG and NEFA levels, and although there was a tendency toward hyperglycemia, this failed to reach statistical significance. Similar to the HFD, HADH activity in obese rats on an MFD was significantly elevated, and PFK and CS activity remained unchanged (Table 3) . Also, aLPL activity was significantly elevated, while mLPL activity remained stable.
GAL measures. The measures of GAL mRNA and peptide-ir in the obese rats on the MFD showed a similar pattern, albeit weaker effect, to that seen on the HFD. There was a small but reliable increase in GAL mRNA and GAL peptide in the anterior parvocellular region of the PVN but no change in the ARC (Table 3) . Moreover, PVN GAL mRNA in these rats was positively correlated specifically with TG levels (r ¼ þ 0.63, Po0.05) and HADH activity (r ¼ þ 0.59, Po0.05), with similar correlations seen for GAL-ir. These measures of GAL were unrelated to levels of NEFA or the different hormones.
Experiment 3: obesity on an HCD with 10% fat
In this experiment, rats were maintained on an HCD with 65% carbohydrate (containing 70% sucrose) and 10% fat, for a period of 5 weeks, to allow sufficient time to differentiate rats based on their body fat accrual. They were subgrouped as lean or obese (n ¼ 9/group), with fat pad weights of 15.170.6 g and 26.471.3 g body fat, respectively, similar to that on the HFD. The results in these rats (Table 4 ) revealed characteristics of obesity on an HCD that were similar as well as different from those seen in obese rats on an MFD or HFD.
Similar characteristics of obesity across diet. Similar to the animals on the HFD (Table 2 ) and MFD (Table 3) , the obese rats on an HCD, with approximately 75% greater fat pad weights, exhibited a significant increase in body weight, % body fat, and weight gain compared to the lean rats (Table 4) . They also had elevated levels of leptin and insulin and showed greater activity of aLPL, with no change in mLPL. These patterns were observed despite the smaller difference in mean body weight of the two HCD subgroups ( þ 38 g) relative to the HFD ( þ 60 g) and MFD ( þ 65 g) subgroups.
Distinct characteristics of obesity on an HCD. Of particular note are the measures revealing distinct differences between the phenotype of obesity on an HCD (Table 4) and that on an HFD (Table 2) or MFD (Table 3) . These include caloric intake, which remained unchanged in the HCD obese rats across all 5 weeks (Table 4) , including week 1 (98 vs 96 kcal) and week 2 (95 vs 99 kcal), in contrast to the hyperphagia exhibited by the HFD or MFD obese animals. Further, circulating levels of CORT and glucose remained stable in the HCD-induced obese rats, while they were reduced or increased, respectively, in the HFD obese group. The most notable differences between the obesities were detected in the measures of circulating lipids, fat oxidation, and GAL expression in the PVN. While TG and NEFA levels and HADH activity in Obesity on a high-carbohydrate vs high-fat diet JT Dourmashkin et al muscle were all elevated with obesity on the HFD or MFD (Tables 2 and 3 ), the obese rats on the HCD compared to lean animals exhibited normal levels of lipid metabolites and a reduction in HADH activity (Table 4 ). This decrease in muscle capacity to oxidize fat was accompanied by a significant increase in PFK as well as CS activity, which were unaltered in obese rats on the HFD or MFD. Further, with no change in lipids and reduced fat oxidation, the HCD obese rats also failed to exhibit a significant increase in GAL mRNA or GAL-ir in the PVN. Their measures of GAL also showed no correlation with the levels of TG or activity of HADH in muscle. In the ARC, GAL mRNA, and GAL peptide in the obese HCD rats was unaltered compared to the lean rats. These results revealed by direct comparisons between obese and lean rats on a specific diet suggest characteristics of obesity that may vary as a function of diet. As summarized in Table 5 , the obese rats on the HFD or MFD both showed increased caloric intake, TG, and NEFA levels, HADH activity in muscle, and PVN GAL mRNA and peptide, with the only difference between these obese groups being the hyperglycemia on the HFD. This pattern contrasts with that of obese rats on an HCD, which failed to show these various changes and, instead, exhibited a reduction in HADH and increase in PFK activity in muscle. Although Experiments 1-3 and their assays were performed at different times, the group differences appeared strong enough and the between-experiment variability low enough to allow further analyses of the three sets of data using two-factor ANOVA. The results of these tests confirmed the diet-related patterns of obese rats. Specifically, significant group Â diet interactions (Po0.05) were obtained for the measures of caloric intake, lipids, and PVN GAL mRNA and peptide, which were significantly elevated in obese rats on the HFD and MFD but not the HCD. In addition, significant interactions were obtained for the measure of HADH activity in muscle, which while increased with obesity on the HFD and MFD was reduced on the HCD, and also the measure of PFK activity, which was increased specifically in the HCD obese rats. In contrast, significant main effects (Po0.05) with no interactions were obtained for the other parameters, namely, body weight, insulin, leptin, and aLPL activity, which were diet independent and more close related to the elevated body fat. Experiment 4: obesity on an HFD compared to an HCD This experiment tested two additional groups of rats, one on an HFD and one on an HCD, using similar procedures as in Experiments 1 and 3, except that the two groups were tested and their tissues assayed at the same time. Two measures were taken in this experiment, TG levels in trunk blood and GAL mRNA in the PVN using real-time quantitative PCR. As described above, the rats were subgrouped as lean or obese (n ¼ 6/group), with fat pad weights of 16.371.7 g for the lean rats and 29.272.3 g for the obese rats on the HFD and 15.670.5 vs 27.770.9 g, respectively, on the HCD.
Similar to the results of Experiments 1 and 3, these subgroups showed different characteristics of obesity on the HFD vs HCD. As shown in Figure 2 and consistent with Table 5 , rats that became obese on the HFD with 79% heavier fat pads had significantly elevated levels of TG compared to the lean rats (Po0.05). This was not seen in obese rats on the HCD, which with 76% heavier fat pads showed no change in this measure and, when analyzed with the HFD data, yielded a significant group Â diet interaction (Po0.01). Similarly, the obese rats on the HFD exhibited a significant increase in GAL 
For abbreviations, see legend to Table 2 . Values expressed as means7s.e.m. *Po0.05 for comparisons between lean and obese rats. For abbreviations, see legend to Table 2 .
Obesity on a high-carbohydrate vs high-fat diet JT Dourmashkin et al expression (ratio of GAL mRNA/b-actin mRNA) in the PVN, an effect not seen in the obese HCD rats (Figure 2 ). Analysis of these data for both diets produced a significant groupdiet interaction (Po0.01), similar to that observed with mRNA measurements using in situ hybridization (Table 5 ).
Discussion
The results of these experiments revealed specific characteristics of obesity, closely related to body fat, which occur on all three diets independent of fat or carbohydrate composition. They additionally identified other characteristics, related to lipids and fat metabolism in muscle, that vary markedly with diet composition. Compared to lean rats, the obese rats on the three diets exhibited elevated levels of leptin and insulin and increased activity of aLPL. These measures, known to be closely related to body fat accrual, 23, 24, 36 are shown here to rise with adiposity regardless of diet. Of particular interest is the finding that in HCD-induced obesity, these measures increased in the absence of a change in circulating levels of the metabolites, both glucose and lipids. Thus, whereas hyperglycemia and hypertriglyceridemia are common traits of obesity 4, 26, 36 closely related to leptin, insulin, and aLPL, 5,36 they are clearly not essential to the obesity and to the changes in these endocrine and metabolic parameters. Thus, the rise in leptin, insulin, and aLPL common to all diets is more directly linked to the accumulated body fat rather than to the levels of circulating glucose and TG.
Characteristics of obesity on a 25% fat MFD were similar in most respects, but not all, to those observed on a 50% fat HFD. The obese rats on the MFD exhibited hyperphagia and had elevated TG and NEFA levels, as previously described on an HFD. 4, 36 They also showed greater HADH activity in muscle reflecting increased muscle capacity to oxidize fat 37 and had significantly elevated GAL expression and peptide in the PVN as shown on an HFD. 11 Thus, a 25% fat diet is similar to a 50% fat diet in revealing these effects. Whereas no change in the obese rats on these diets was seen in PFK activity, levels of CORT were significantly reduced, as reported previously in moderately obese rodents. 4, 26 This change may reflect the steroid's inverse relation to leptin and lipids, which are known to have an inhibitory effect on CORT. 38, 39 The primary difference between obesity on an MFD vs HFD was detected here in the measure of glucose. Whereas hyperglycemia is typically seen in obese rats on an HFD, as shown here and in other studies, 4, 26, 36 glucose levels
were not significantly elevated in the obese rats on the MFD. This result agrees with other studies showing the importance of dietary fat in producing hyperglycemia together with accrual of body fat, 5, 26 with elevated glucose and insulin/ glucose ratio reflecting fat-induced insulin resistance. 40 The failure of obese MFD rats to exhibit significant hyperglycemia may be related to their somewhat lower level of body fat accrual compared to obese HFD rats, as indicated by their measures of fat pad weights (20 vs 27 g) and % body fat scores (4.2 vs 5.6%). The present findings reveal several characteristics of HCDinduced obesity that are distinctly different from those seen with obesity on an HFD or MFD. One difference is the rate of body fat accrual, with the HCD obese rats requiring 5 weeks to accumulate the same amount of fat as the HFD obese rats did in 3 weeks. This slower rise in body fat very likely reflects the greater efficiency of fat compared to carbohydrate in contributing to the accrual of adipose tissue. 3 It may also be related to the absence of hyperphagia in the HCD obese rats, as shown here and in other studies of rats or inbred mice on carbohydrate-rich diets. 4, 14, 26 The finding that HCD obese rats exhibit little change in circulating levels of glucose and lipid metabolites further substantiates the link between excess dietary fat and both hyperglycemia and hyperlipidemia seen in HFD obese rats. 5, 26 The normal levels of CORT in HCD-induced obesity, in contrast to the reduced levels in HFD-or MFD-induced obesity, suggests that the elevated lipids in the latter may be affecting this steroid. 39 A critical difference between the obesities on the different diets was further revealed by the measures of HADH and PFK activity, which reflect the capacity of muscle to metabolize fat and carbohydrate, respectively. Whereas HADH together with TG levels and caloric intake increased significantly in obese rats on the HFD or MFD, a reduction in HADH activity was detected with obesity on the HCD, which had normal levels of TG. Also, the activity of PFK was significantly enhanced in HCD obese rats, as previously reported, 27 while unchanged in the HFD or MFD obese animals. These findings provide evidence for a specific metabolic phenotype in HCDinduced obesity, a reduced muscle capacity to metabolize fat relative to carbohydrate, which likely contributes to the development of obesity. [41] [42] [43] This metabolic pattern, absent in obese rats on an HFD. 37 can be seen only when obesity develops without a rise in TG levels, as shown here, or in a pre-obese state of obesity-prone rats. Obesity on a high-carbohydrate vs high-fat diet JT Dourmashkin et al
The results here demonstrate that obesity on an HFD or an MFD is also accompanied by an increase in GAL expression and peptide level in the anterior parvocellular region of the PVN. This peptide in the PVN is also consistently, positively correlated with TG levels and measures of fat metabolism in muscle, while it can be dissociated from a rise in body fat. These findings suggest a role specifically for processes of fat metabolism in controlling the expression of endogenous PVN GAL. This idea receives support from published evidence, showing similar relationships in rats exposed for brief periods to an HFD vs HCD independent of changes in body fat 6 and demonstrating that pharmacological blockade of fat oxidation reduces PVN GAL mRNA 44 while stimulating PVN GAL-R1 mRNA. 45 Also, reduced fat oxidation induces a feeding response that is blocked by a GAL receptor antagonist. 46 Further support for a relationship between fat metabolism and PVN GAL is provided by evidence obtained in the obese rats on an HCD. With TG levels unaltered and HADH activity reduced, these rats exhibited no change in PVN GAL mRNA and peptide-ir and no consistent correlations between GAL and these fat-related measures. The finding that injection of Intralipid increases GAL expression while raising TG levels suggests that circulating lipids, rather than dietary fat per se, are more important in the stimulation of PVN GAL. 47 This possibility may be further tested using a sucrose or fructose-rich HCD, which has a stronger effect in raising circulating TG, [48] [49] [50] an effect not seen here on an HCD with a relatively high starch content (Tables 1 and 4) . In contrast to lipids, GAL appears to be weakly related to measures of insulin and leptin. The HCD-induced obese rats showed no change in PVN GAL, despite markedly elevated levels of these hormones similar to the other diet groups. Also, there were no consistent correlations between GAL and these hormones in any of the groups tested. This strong, positive relationship to circulating lipids and fat metabolism suggests that endogenous PVN GAL may contribute to obesity only on an HFD but not an HCD. This idea is substantiated by evidence showing that GAL injection has obesity-promoting effects that are more pronounced on diets rich in fat. The changes induced by acute GAL injection include hyperphagia, [51] [52] [53] reduced energy expenditure and sympathetic nervous system activity, 7, 54, 55 and a suppression of HADH together with increased PFK activity in muscle. 56 The GAL-stimulated feeding response is stronger and more prolonged in subgroups or strains of rats that naturally prefer fat or are maintained on an HFD compared to an HCD. 53, 57 Also, chronic GAL injections, while having little impact on body weight on an HCD with 10% fat, 58 can significantly increase fat pad weights on an HFD with 50-60% fat and can produce a rise in leptin, TG, and NEFA levels together with aLPL activity. 29 Thus, under physiological conditions, the role of GAL in eating and body weight regulation may be expressed only on fat-rich diets. An additional finding of this study is that GAL in the ARC, in contrast to the PVN, shows no change in obese compared to lean rats on an HFD or MFD. This is consistent with additional analyses, performed here and in published studies, 6, 11, 59 demonstrating that GAL in the ARC is unaffected or even reduced by chronic or acute HFD consumption and shows no consistent or sometimes inverse correlations with TG levels, fat metabolism or body fat. It also responds differently from PVN GAL to injections of various hormones that are altered by an HFD. [60] [61] [62] [63] Thus, GAL in the ARC clearly differs from PVN GAL and is likely to have a different role, if any, in producing obesity on an HFD.
Conclusion
The present results demonstrate that the type of obesity resulting on an HCD differs from that produced by a diet with higher fat content ( Table 5 ). The HFD-induced obesity is associated with hyperphagia and a compensatory rise in fat metabolism, and it exhibits an elevation of circulating lipids, glucose, and GAL expression in the PVN. This contrasts markedly with HCD-induced obesity, which shows little change in caloric intake, metabolite levels and PVN GAL, while exhibiting a metabolic pattern in muscle that favors carbohydrate over fat oxidation. These results underscore the existence of multiple forms of obesity and demonstrate the importance of diet composition in revealing specific phenotypes and mechanisms underlying these different types of obesity. Further tests are needed to determine whether the rats that become obese on an HFD are genetically similar to those exhibiting obesity on an HCD or whether they have different genetic susceptibilities to diet composition. It would also be interesting to know whether the rats that remain lean on either diet have specific leanness susceptibility genes.
